Zöllner, Johann Philipp http://orcid.org/0000-0002-7245-2562
Misselwitz, Björn
Mauroschat, Thomas
Roth, Christian
Steinmetz, Helmuth
Rosenow, Felix
Strzelczyk, Adam http://orcid.org/0000-0001-6288-9915
Funding for this research was provided by:
LOEWE Center for Personalized Translational Epilepsy Research (CePTER), Goethe University Frankfurt, Frankfurt am Main, Hessen, Germany
Projekt DEAL
Article History
Received: 16 September 2020
Accepted: 19 November 2020
First Online: 3 December 2020
Competing interests
: JPZ reports a speaker’s honorarium from Eisai and Desitin Arzneimittel outside the submitted work. FR reports personal fees from Arvelle Therapeutics, EISAI, GW-Pharmaceuticals, Desitin Pharma, Medtronic, Shire; personal fees and other fees from Novartis and UCB Pharma; and grants from the European Union, the German Minister for Education and Research (BMBF), the LOEWE Program of the federal state of Hessen, the Deutsche Forschungsgemeinschaft (DFG), and the Detlev-Wrobel-Fonds for Epilepsy Research, outside the submitted work. AS reports personal fees and/or grants from Arvelle Therapeutics, Desitin Arzneimittel, Eisai, GW Pharmaceuticals, LivaNova, Marinus Pharmaceuticals, Medtronic, UCB Pharma, and Zogenix, outside the submitted work. None of the other authors reports competing interests.